Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MK-0941 free base is an orally active glucokinase activator, exhibiting strong glucose-lowering activity and is a potential therapeutic agent for treatment of type 2 diabetes.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 30,500 | |||
5 mg | 在庫あり | ¥ 69,500 | |||
10 mg | 在庫あり | ¥ 104,000 | |||
25 mg | 在庫あり | ¥ 171,500 | |||
50 mg | 在庫あり | ¥ 241,000 | |||
100 mg | 在庫あり | ¥ 326,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 84,000 |
説明 | MK-0941 free base is an orally active glucokinase activator, exhibiting strong glucose-lowering activity and is a potential therapeutic agent for treatment of type 2 diabetes. |
In vivo | MK-0941 free base treatment reduced blood glucose significantly in db/db diabetic mouse[1]. |
分子量 | 460.5 |
分子式 | C21H24N4O6S |
CAS No. | 752240-01-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 9 mg/mL (19.54 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-0941 free base 752240-01-0 Metabolism Glucokinase MK0941 free base MK0941 Hexokinase IV MK 0941 MK-0941 MK 0941 free base Inhibitor inhibit Hexokinase D inhibitor